Halozyme Therapeutics, Inc. (HALO) is near the top in its industry group according to InvestorsObserver. HALO gets an overall rating of 46. That means it scores higher than 46 percent of stocks. Halozyme Therapeutics, Inc. gets a 67 rank in the Biotechnology industry. Biotechnology is number 88 out of 148 industries.
HALO has an Overall Score of 46. Find out what this means to you and get the rest of the rankings on HALO!